Literature DB >> 23599192

The functional results of acute nerve grafting in traumatic sciatic nerve injuries.

Haluk Vayvada1, Cenk Demirdöver, Adnan Menderes, Mustafa Yılmaz, Can Karaca.   

Abstract

BACKGROUND: The sciatic and peroneal nerves are the most frequently injured in lower extremities, followed by tibial and femoral nerves. The aim of this study is to evaluate the functional results of acute nerve grafting in traumatic sciatic nerve injuries.
METHODS: A total of 9 patients with sciatic nerve defect were treated with primary nerve grafting. The mean age was 31.7 years. The etiologic factors were gunshot wounds, traffic accident, and penetrating trauma.
RESULTS: All of the patients had sciatic nerve defects ranging from 3.4 to 13.6 cm. The follow-up period ranged between 25 and 84 months. The tibial nerve motor function was "good" or "very good" (M3-M4) in 5 patients (55.6%). The plantar flexion was not sufficient for the rest of the patients. The peroneal nerve motor function was also "good" and "very good" in 3 patients (33.3%).
CONCLUSION: The functional results of the acute nerve grafting of the sciatic nerve within the first week after the injury are poorer than reported in the related literature. This protocol should only be applied to select patients who have adequate soft tissue coverage and healthy nerve endings.

Entities:  

Mesh:

Year:  2013        PMID: 23599192     DOI: 10.5505/tjtes.2013.33279

Source DB:  PubMed          Journal:  Ulus Travma Acil Cerrahi Derg


  2 in total

Review 1.  Ballistic peripheral nerve injuries: basic concepts, controversies, and proposal for a management strategy.

Authors:  Laurent Mathieu; Melody Goncalves; James Charles Murison; Georges Pfister; Christophe Oberlin; Zoubir Belkheyar
Journal:  Eur J Trauma Emerg Surg       Date:  2022-03-09       Impact factor: 2.374

2.  Nerve trauma of the lower extremity: evaluation of 60,422 leg injured patients from the TraumaRegister DGU® between 2002 and 2015.

Authors:  Torge Huckhagel; Jakob Nüchtern; Jan Regelsberger; Mathias Gelderblom; Rolf Lefering
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2018-05-15       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.